Suppr超能文献

5型腺病毒复制中E1B-55K对p53的非依赖性和依赖性需求

p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.

作者信息

Harada J N, Berk A J

机构信息

Molecular Biology Institute, University of California-Los Angeles, Los Angeles, California 90095-1570, USA.

出版信息

J Virol. 1999 Jul;73(7):5333-44. doi: 10.1128/JVI.73.7.5333-5344.1999.

Abstract

The adenovirus type 5 mutant dl1520 was engineered previously to be completely defective for E1B-55K functions. Recently, this mutant (also known as ONYX-015) has been suggested to replicate preferentially in p53(-) and some p53(+) tumor cell lines but to be attenuated in primary cultured cells (C. Heise, A. Sampson-Johannes, A. Williams, F. McCormick, D. D. F. Hoff, and D. H. Kirn, Nat. Med. 3:639-645, 1997). It has been suggested that dl1520 might be used as a "magic bullet" that could selectively lyse tumor cells without harm to normal tissues. However, we report here that dl1520 replication is independent of p53 genotype and occurs efficiently in some primary cultured human cells, indicating that the mutant virus does not possess a tumor selectivity. Although it was not the sole host range determinant, p53 function did reduce dl1520 replication when analyzed in a cell line expressing temperature-sensitive p53 (H1299-tsp53) (K. L. Fries, W. E. Miller, and N. Raab-Traub, J. Virol. 70:8653-8659, 1996). As found earlier for other E1B-55K mutants in HeLa cells (Y. Ho, R. Galos, and J. Williams, Virology 122:109-124, 1982), dl1520 replication was temperature dependent in H1299 cells. When p53 function was restored at low temperature in H1299-tsp53 cells, it imposed a modest defect in viral DNA replication and accumulation of late viral cytoplasmic mRNA. However, in both H1299 and H1299-tsp53 cells, the defect in late viral protein synthesis appeared to be much greater than could be accounted for by the modest defects in late viral mRNA levels. We therefore propose that in addition to countering p53 function and modulating viral and cellular mRNA nuclear transport, E1B-55K also stimulates late viral mRNA translation.

摘要

5型腺病毒突变体dl1520之前经过改造,使其E1B - 55K功能完全缺陷。最近,有人提出这种突变体(也称为ONYX - 015)优先在p53(-)和一些p53(+)肿瘤细胞系中复制,但在原代培养细胞中减毒(C. Heise、A. Sampson - Johannes、A. Williams、F. McCormick、D. D. F. Hoff和D. H. Kirn,《自然医学》3:639 - 645,1997年)。有人提出dl1520可能用作“神奇子弹”,可选择性裂解肿瘤细胞而不损害正常组织。然而,我们在此报告,dl1520的复制不依赖于p53基因型,且在一些原代培养的人细胞中高效发生,表明该突变病毒不具有肿瘤选择性。虽然p53功能不是唯一的宿主范围决定因素,但在表达温度敏感型p53的细胞系(H1299 - tsp53)中分析时,p53功能确实降低了dl1520的复制(K. L. Fries、W. E. Miller和N. Raab - Traub,《病毒学杂志》70:8653 - 8659,1996年)。如先前在HeLa细胞中对其他E1B - 55K突变体的研究发现(Y. Ho、R. Galos和J. Williams,《病毒学》122:109 - 124,1982年),dl1520在H1299细胞中的复制是温度依赖性的。当在H1299 - tsp53细胞中低温恢复p53功能时,它对病毒DNA复制和晚期病毒细胞质mRNA的积累造成适度缺陷。然而,在H1299和H1299 - tsp53细胞中,晚期病毒蛋白合成的缺陷似乎比晚期病毒mRNA水平的适度缺陷所能解释的要大得多。因此,我们提出,除了对抗p53功能和调节病毒及细胞mRNA的核转运外,E1B - 55K还刺激晚期病毒mRNA的翻译。

相似文献

引用本文的文献

3
Oncolytic Viruses and Cancer, Do You Know the Main Mechanism?溶瘤病毒与癌症,你了解其主要机制吗?
Front Oncol. 2021 Dec 22;11:761015. doi: 10.3389/fonc.2021.761015. eCollection 2021.
6
Concepts in Oncolytic Adenovirus Therapy.溶瘤腺病毒治疗的概念。
Int J Mol Sci. 2021 Sep 29;22(19):10522. doi: 10.3390/ijms221910522.
8
The Oncolytic Virus in Cancer Diagnosis and Treatment.溶瘤病毒在癌症诊断与治疗中的应用
Front Oncol. 2020 Sep 9;10:1786. doi: 10.3389/fonc.2020.01786. eCollection 2020.

本文引用的文献

5
Cancer. Has the smart bomb been defused?
Nature. 1998 Sep 3;395(6697):13, 15. doi: 10.1038/25595.
7
Killing tumor cells with viruses--a question of specificity.
Nat Med. 1998 Sep;4(9):1012-3. doi: 10.1038/2000.
8
Adenovirus E1B 55K represses p53 activation in vitro.腺病毒E1B 55K蛋白在体外抑制p53激活。
J Virol. 1998 Apr;72(4):3146-54. doi: 10.1128/JVI.72.4.3146-3154.1998.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验